These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17433231)

  • 21. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
    Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
    Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
    Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conclusions. The precautionary principle: its advantages and risks].
    Tubiana M
    Bull Acad Natl Med; 2000; 184(5):969-93. PubMed ID: 11077719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing strategies for hepatitis B vaccination.
    Alavian SM; Fallahian F; Lankarani KB
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):10-22. PubMed ID: 20061687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MeNZB vaccine and epidemic control: when do you stop vaccinating?
    Loring BJ; Turner N; Petousis-Harris H
    Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A crisis of public confidence in vaccines.
    Black S; Rappuoli R
    Sci Transl Med; 2010 Dec; 2(61):61mr1. PubMed ID: 21148125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
    Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
    Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
    Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The National Advisory Group on Immunization (NAGI) of the Republic of South Africa.
    Schoub BD; Ngcobo NJ; Madhi S
    Vaccine; 2010 Apr; 28 Suppl 1():A31-4. PubMed ID: 20412993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.
    Broder KR; MacNeil A; Malone S; Schwartz B; Baughman AL; Murphy TV; Pickering LK; Moran JS
    Pediatrics; 2005 Jun; 115(6):1479-87. PubMed ID: 15930207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.
    Dasbach EJ; Elbasha EH; Insinga RP
    Epidemiol Rev; 2006; 28():88-100. PubMed ID: 16740585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey.
    Gilca V; Boulianne N; Dubé E; Sauvageau C; Ouakki M
    Int J Nurs Stud; 2009 Sep; 46(9):1219-35. PubMed ID: 19349047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.